Self Care Catalysts Partners with Carcinoid Cancer Foundation to Help Carcinoid and Neuroendocrine Tumor (NET) Patients Take Control of Their Rare DiseasesDecember 7, 2014
Patient intelligence health solution provider Self Care Catalysts and the Carcinoid Cancer Foundation announced today a new partnership to provide people diagnosed with carcinoid cancer and neuroendocrine tumors (NETs), including pancreatic NETs, with a new mobile patient support tool to help them take control of their rare disease journey.
According to the first global survey of patients with NETs, 41% of patients believe that a better understanding of how to manage their diseaserelated symptoms would help them to live a better life. Another 60% of those surveyed feel their emotional health is negatively affected by having NETs.
Read the full article here.